-
Symbol
-
LVTX
-
Investment type
-
Equity / Common shares, Euro 0.12 nominal value per share
-
Latest Disclosed Shares Owned
-
0 shares
-
Security Ownership %
-
0%
Versant Venture Capital VI, L.P. ownership in LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX)
23 Sep 2025 - Versant Venture Capital VI, L.P. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 0 shares of LAVA Therapeutics NV Common shares, Euro 0.12 nominal value per share (LVTX).
This represents 0% ownership of the company.
In their previous filing dated 18 Sep 2025, Versant Venture Capital VI, L.P. had reported owning 2,370,533 shares, indicating a decrease of +100%.
.